>>MEDFONE Aids Pharmaceutical Company In Its Quest To Treat Multiple Sclerosis Patients
A leading, publicly traded, international pharmaceutical company embarked on a 180-patient, international clinical trial to test their newly developed drug treatment against the currently approved medication for Multiple Sclerosis sufferers. If the trial proves successful, this study will require a larger clinical trial so the company can apply for regulatory approval of the drug. This company needed a call center to handle incoming calls from various countries in several languages and to screen potential participants for eligibility in the study. After eligibility is determined, participants need to be assigned to a facility in their area where the study is being conducted.
MEDFONE has assisted this pharmaceutical company by developing clinical trial recruitment campaigns with customized inbound live agent, Interactive Voice Response (IVR), and email management solutions. All calls are being handled by a team set up to determine eligibility of potential participants, as well as, provide them with contact information and a clinical study site in their area.
MEDFONE has optimized the enrollment process by screening and registering 74% of the required patient base in less than two months.
MEDFONE’s programs have yielded results that are 21% better than the client expected. The client has also reduced its time and expenses by outsourcing the screening process to
MEDFONE. All the while the company is able to focus on the more important aspects of what they are trying to achieve – developing the treatment. As the clinical trial progresses faster than the company expected, upon its conclusion, this company will be able to gain regulatory approval for the use of this drug sooner than ever anticipated.
|
